Acorah Software Products - Accounts Production 16.8.200 false true 31 October 2024 1 November 2023 false true No description of principal activity 1 November 2024 31 October 2025 31 October 2025 09584281 D Shehab iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 09584281 2024-10-31 09584281 2025-10-31 09584281 2024-11-01 2025-10-31 09584281 frs-core:CurrentFinancialInstruments 2025-10-31 09584281 frs-bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 09584281 frs-bus:FilletedAccounts 2024-11-01 2025-10-31 09584281 frs-bus:Micro-entities 2024-11-01 2025-10-31 09584281 frs-bus:AuditExempt-NoAccountantsReport 2024-11-01 2025-10-31 09584281 frs-bus:Director1 2024-11-01 2025-10-31 09584281 2023-10-31 09584281 2024-10-31 09584281 2023-11-01 2024-10-31 09584281 frs-core:CurrentFinancialInstruments 2024-10-31
Registered number: 09584281
Medox Ltd
Unaudited Financial Statements
For The Year Ended 31 October 2025
Balance Sheet
Registered number: 09584281
2025 2024
£ £
Current assets 7,529 6,919
Creditors: Amounts Falling Due Within One Year (1,839 ) (1,229 )
NET CURRENT ASSETS 5,690 5,690
TOTAL ASSETS LESS CURRENT LIABILITIES 5,690 5,690
NET ASSETS 5,690 5,690
CAPITAL AND RESERVES 5,690 5,690

Notes

1. General Information
Medox Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 09584281 . The registered office is 113 Stoneleigh Avenue, Worcester Park, Surrey, KT4 8XZ.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2024: 1)
1 1
For the year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
D Shehab
Director
24/12/2025